Photographer: Qilai Shen/Bloomberg Photographer: Qilai Shen/Bloomberg Stocks rose in Europe along with U.S. equity futures as optimism crept into markets that Tuesday’s tumble in America may have drawn a line under the recent sell-off. European shares climbed broadly as investors took in stride news that AstraZeneca Plc had to pause its trials of a leading experimental Covid-19 vaccine when a participant got sick. Contracts on the S&P 500 and Nasdaq 100 advanced in the wake of large declines in America that were led by tech shares. Treasuries and the dollar erased their increases as equity futures strengthened. The pound headed for its longest declining streak since March on worries that talks could collapse over changes to the Brexit withdrawal deal. Global investors are grappling with the recent market turbulence, assessing whether the pullback for equities is a sign of market health or the start of a larger drawdown that has further to go. “We don’t know exactly if this is the bottom, there could be more volatility,” Laila Pence, president of Pence Wealth Management, said on Bloomberg TV. “We’re taking the froth out of the market.” Elsewhere, Brent crude hovered at around $40 amid further signs of a bleak short-term outlook. Yields on New Zealand’s three-year bonds dropped into negative territory for the first time. Here are some key events coming up: AstraZeneca has paused research on its experimental coronavirus vaccine after a person who is participating in a clinical trial became ill. Source: Bloomberg These are the main moves in markets: — With assistance by Andreea Papuc, Gregor Stuart Hunter, and Adam Haigh